Stay updated with breaking news from Optic Neuropathy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results of the 30-month data cut of the 3-year GALE open-label extension trial of pegcetacoplan for geographic atrophy showed that the drug produced clinically meaningful reductions in lesion growth.
Patients with a progressive form of Leber hereditary optic neuropathy (LHON) that causes rapid vision loss experienced improvement in their eyesight with an experimental gene therapy.
Real-world data (RWD) has proven to be valuable in studying rare diseases. Incorporating RWD has led to the identification of previously undetected...
People fully vaccinated against the Wuhan coronavirus (COVID-19) are now becoming blind. The latest data out of the United Kingdom's Yellow Card system, the counterpart of Vaccine Adverse [...]
Chris Delaney has spent his whole life defying the odds - living the old adage that, when life hands you lemons, you make lemonade.